And an even more powerful medication called retatrutide is being tested now and could receive FDA approval in 2027
Mounjaro is approved for type 2 diabetes treatment, while Zepbound targets weight loss
Common Side Effects GLP-1 medications like semaglutide and tirzepatide are known to cause mild to moderate side effects, especially in the early weeks
Retatrutide's potency also comes with a dose-dependent side-effect profile predominantly gastrointestinal and the deepest appetite suppression of the class, which is the very thing that can drive protein too low
While other weight loss medications, like phentermine, have stimulating effects that help curb your appetite, Semaglutide works differently
This means food stays in your stomach longer, keeping you physically full